Qube Research & Technologies (QRT)’s Jasper Therapeutics JSPR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2K	Buy	+33,722	New	+$25.2K	﹤0.01%	3252

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s JSPR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Jasper Therapeutics (JSPR) in Q2 2026: 33,722 shares worth $14.2K. The stake represents ﹤0.01% of the portfolio and ranks #3252 among its holdings.

45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

Qube Research & Technologies (QRT) held 33,722 shares of Jasper Therapeutics worth $14.2K as of Q2 2026.
Jasper Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
Jasper Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3252 holding.
45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.